Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

The VMH AMPK-SNS-BAT axis may help treat cachexia and obesity.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Using urinary bladder matrix and platelet rich plasma can effectively treat transplant scars and prevent hair loss.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

MPZL3 is important for controlling the hair growth cycle in mice and humans.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

MXD@CP could be a promising new topical treatment for hair loss.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Suppressing ODC activity reduces tumor growth in hair follicles.

Bicalutamide may help treat female pattern hair loss.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.